Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
ARS Pharmaceuticals, Inc. (SPRY)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
29 Feb 2024
Lowenthal Richard E
PRESIDENT AND CEO, Director, Officer, 10% Owner
ARS Pharmaceuticals, Inc.
(SPRY)
1,746,494
-0%
3,782
$9.02
$34,100.58
SELL
29 Feb 2024
Tanimoto Sarina
CHIEF MEDICAL OFFICER, Officer, 10% Owner
ARS Pharmaceuticals, Inc.
(SPRY)
1,746,494
-0%
3,782
$9.02
$34,100.58
SELL
26 Feb 2024
Lowenthal Richard E
PRESIDENT AND CEO, Director, Officer, 10% Owner
ARS Pharmaceuticals, Inc.
(SPRY)
1,747,294
-5%
99,478
$9.02
$897,368.25
SELL
26 Feb 2024
Tanimoto Sarina
CHIEF MEDICAL OFFICER, Officer, 10% Owner
ARS Pharmaceuticals, Inc.
(SPRY)
1,747,294
-5%
99,478
$9.02
$897,368.25
BUY
21 Sep 2023
RA CAPITAL MANAGEMENT, L.P.
Director
ARS Pharmaceuticals, Inc.
(SPRY)
8,365,465
+47%
2,700,000
$3.03
$8,183,526.00
SELL
1 Sep 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-32%
100,000
$7.71
$770,520.00
BUY
29 Aug 2023
Thompson Peter A.
Director
ARS Pharmaceuticals, Inc.
(SPRY)
8,019,187
+6%
500,000
$6.20
$3,100,000.00
BUY
29 Aug 2023
RA CAPITAL MANAGEMENT, L.P.
Director
ARS Pharmaceuticals, Inc.
(SPRY)
5,856,774
+177%
3,750,000
$6.20
$23,250,000.00
BUY
29 Aug 2023
ORBIMED ADVISORS LLC
Director
ARS Pharmaceuticals, Inc.
(SPRY)
8,019,187
+6%
500,000
$6.20
$3,100,000.00
SELL
3 Aug 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-17%
45,004
$7.03
$316,489.30
SELL
1 Aug 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-20%
54,996
$7.12
$391,840.75
SELL
7 Jul 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-4%
8,858
$6.36
$56,372.31
SELL
3 Jul 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-30%
91,142
$6.48
$590,453.30
SELL
1 Jun 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-32%
100,000
$6.84
$684,041.10
BUY
29 Nov 2022
Scott Kathleen D.
Chief Financial Officer, Officer
ARS Pharmaceuticals, Inc.
(SPRY)
8,250
+100%
8,250
$6.24
$51,506.40
BUY
3 Mar 2021
ROOT JONATHAN D
Director
Silverback Therapeutics, Inc.
(SBTX)
2,364
+100%
2,364
$15.25
$36,048.40
BUY
8 Dec 2020
ROOT JONATHAN D
Director
Silverback Therapeutics, Inc.
(SBTX)
95,238
+100%
95,238
$21.00
$1,999,998.00
BUY
8 Dec 2020
CAPPS VICKIE L
Director
Silverback Therapeutics, Inc.
(SBTX)
61,576
+18%
9,523
$21.00
$199,983.00
BUY
8 Dec 2020
Presidio Management Group XII, L.L.C.
10% Owner
Silverback Therapeutics, Inc.
(SBTX)
47,619
+100%
47,619
$21.00
$999,999.00
BUY
8 Dec 2020
Hawkinson Russ
Sr. Vice President of Finance, Officer
Silverback Therapeutics, Inc.
(SBTX)
238
+100%
238
$21.00
$4,998.00
BUY
8 Dec 2020
Schroeder Thilo
Director
Silverback Therapeutics, Inc.
(SBTX)
238,096
+100%
238,096
$21.00
$5,000,016.00
BUY
8 Dec 2020
Piazza Jonathan
Chief Financial Officer, Officer
Silverback Therapeutics, Inc.
(SBTX)
11,904
+100%
11,904
$21.00
$249,984.00
BUY
8 Dec 2020
Thompson Peter A.
Director, 10% Owner
Silverback Therapeutics, Inc.
(SBTX)
507,423
+174%
1,190,477
$21.00
$25,000,016.00
BUY
8 Dec 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
Silverback Therapeutics, Inc.
(SBTX)
507,423
+174%
1,190,477
$21.00
$25,000,016.00
Home